Joan E. Delovitch, M.S., L.C.M.F.T. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 15312 Spencerville Ct, Suite 301, Burtonsville, MD 20866 Phone: 301-421-9100 |
Mary K. Hargadon-zester, M.S., L.C.M.F.T. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 15312 Spencerville Ct, Suite 301, Burtonsville, MD 20866 Phone: 301-421-9100 |
News Archive
Thanks to a new $2 million investment, a drug that spurs cancer cells to self-destruct while sparing healthy cells is on the road to human clinical trials. The compound, known as PAC-1, has so far proven safe and has promising anti-cancer effects in cell culture, in mouse models of cancer and in pet dogs with spontaneously occurring lymphomas and osteosarcomas.
A Phase I clinical trial led by investigators from the University of California, San Francisco and sponsored by Stem Cells Inc., showed that neural stem cells successfully engrafted into the brains of patients and appear to have produced myelin.
Individuals taking a medication to treat depression may experience changes in their personality separate from the alleviation of depressive symptoms, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Now that scientists have learned so much about aging through laboratory studies, it's time to translate those findings into medicines that can benefit our aging population. That was the message delivered by a panel of 10 preeminent aging experts that included Jan Vijg, Ph.D., chair of genetics and the Lola and Saul Kramer Chair in Molecular Genetics at Albert Einstein College of Medicine of Yeshiva University.
The Senate Finance Committee on Tuesday hold the first of at least eight congressional hearings focusing on strategies to reform the U.S. health care system, featuring testimony by former HHS secretaries Tommy Thompson and Donna Shalala, CQ HealthBeat reports.
› Verified 7 days ago